SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Intimation for Considering Fund Raising
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2021 ,inter alia, to consider and approve / evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. Sun Pharma Advanced Research Company Ltd - 532872 - Submission Of Certificate From Statutory Auditor In Terms Of Regulation 169(5) Of The Securities And Exchange Board Of India (Issue Of Capital And Disclosure Requirements) Regulations, 2018 ('ICDR Regulations')
Pursuant to Regulation 169(5) of the ICDR Regulations, please find enclosed herewith, a certificate issued by S RB C & Co LLP, Chartered Accountants, Statutory Auditors of the Company, certifying that the issuer (i.e. Company) is in compliance with Regulation 169(4) of ICDR Regulations and the relevant documents thereof are maintained by the issuer as on the date of the certificate. SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of loss of share certificates/request for issue of duplicate share certificate reported by shareholder of the Company, received from our Registrar and Transfer Agent, Link Intime India Private Limited on August 25, 2021 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Allotment
Intimation of Outcome of the meeting of the Securities Allotment Committee held today i.e. on August 25, 2021 in terms of Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Details of allotment are given in the attahed Intimation letter. Sun Pharma Advanced Research Company Ltd - 532872 - Appointment of Company Secretary and Compliance Officer
As per letter attached Sun Pharma Advanced Research Company Ltd - 532872 - Outcome Of The Board Meeting Held Today I.E. July 26, 2021
As per letter attached Sun Pharma Advanced Research Company Ltd - 532872 - Outcome Of The Board Meeting Held Today I.E. July 26, 2021
As per letter attached Sun Pharma Advanced Research Company Ltd - 532872 - Shareholding for the Period Ended June 30, 2021
Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here Sun Pharma Advanced Research Company Ltd - 532872 - Submission Of Certificate From Statutory Auditor In Terms Of Regulation 169(5) Of The Securities And Exchange Board Of India (Issue Of Capital And Disclosure Requirements) Regulations, 2018 ('ICDR Regulations')
Pursuant to Regulation 169(5) of the ICDR Regulations, please find enclosed herewith, a certificate issued by S R B C & Co LLP, Chartered Accountants, Statutory Auditors of the Company, certifying that the issuer (i.e. Company) is in compliance with Regulation 169(4) of ICDR Regulations and the relevant documents thereof are maintained by the issuer as on the date of the certificate. Sun Pharma Advanced Research Company Ltd - 532872 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- CHETAN RAJPARADesignation :- Chief Financial Officer